Article

Identification of active molecules against Mycobacterial Shikimate Kinase from Chemical library and their affinity with different domains

2020-11-09

Abstract excerpt

Tuberculosis (TB), regardless of being the oldest disease is still a menace that humans have not been able to control. With the advancement in the drug discovery programme, target-based drug discovery appears to be one of the promising techniques for the development of future therapeutics. It involves identifying an essential gene involved in the pathogenesis of the disease and then targeting the protein against a...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 71705a7e-5a2c-5c9b-86a5-8875c953f432
DOI: 10.22541/au.160491622.24853329/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Identification of active molecules against Mycobacterial Shikimate Kinase from Chemical library and their affinity with different domainsDOI 10.22541/au.160491622.24853329/v1Read

Homogeneous recombinant Mycobacterium tuberculosis shikimate dehydrogenase production: an essential step towards target-based drug design.Semantic proximity Read

Unlocking Herbal Potentials: Novel Shikimate Kinase Inhibitors in the Fight Against Antibiotic ResistanceSemantic proximity Read

Shikimate dehydrogenase structure reveals novel fold.Semantic proximity Read

Identification of KasA as the cellular target of an anti-tubercular scaffold.Semantic proximity Read

Structural and Biochemical Analyses Reveal that Chlorogenic Acid Inhibits the Shikimate PathwaySemantic proximity Read

Identification of the anti-mycobacterial functional properties of piperidinol derivatives.Semantic proximity Read

Identification of novel drug targets for Helicobacter pylori: structure-based virtual screening of potential inhibitors against DAH7PS protein involved in the shikimate pathwaySemantic proximity Read

Structure-Based Drug Design for Tuberculosis: Challenges Still AheadSemantic proximity Read

Genome mining of Mycobacterium tuberculosis: targeting SufD as a novel drug candidate through in silico characterization and inhibitor screeningSemantic proximity Read

Discovery of a Natural Product That Binds to the Mycobacterium tuberculosis Protein Rv1466 Using Native Mass SpectrometrySemantic proximity Read

Identification and Validation of Novel Drug Targets in TuberculosisSemantic proximity Read

Molecular docking, molecular dynamics simulations and binding free energy studies of interactions between Mycobacterium tuberculosis Pks13, PknG and bioactive constituents of extremophilic bacteriaSemantic proximity Read